Find by identifier
CAS number index
39,377 CAS Registry Numbers in numeric order. A number with several grades opens a comparison page, a single match opens the product.
| CAS number | Substance | Listings |
|---|---|---|
| 197251-11-9 | Tamoxifen Citrate EP Impurity D | 1 |
| 197291-75-1 | Ofloxacin EP Impurity D | 1 |
| 197431-02-0 | N-Desbutyl Dronedarone Hydrochloride | 1 |
| 197508-56-8 | Rhodiocyanoside D | 1 |
| 197520-71-1 | Binimetinib Intermediate 2 | 1 |
| 197579-95-6 | N-Boc-glycine isopropylester | 1 |
| 197706-51-7 | (2S,2'R)-6-Fluoro-2-(2'-oxiranyl)chromane | 1 |
| 197721-70-3 | 5-β-Hydroxy Drospirenone | 1 |
| 197895-54-8 | 2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester, Trichloroacetimidate | 1 |
| 197909-66-3 | 1,3''-Di-HABA Kanamycin A | 1 |
| 197909-67-4 | Amikacin EP Impurity F | 1 |
| 197958-29-5 | 2-Pyridylboronic acid | 1 |
| 198014-94-7 | Bacosine | 1 |
| 198139-38-7 | 1-(4-Methoxybenzyl)-2,3-dihydro-imidazo[1,2-a]pyridin-1-ium | 1 |
| 198213-15-9 | Sodium 5-(methoxycarbonyl)-6-oxo-1,2,3,6-tetrahydropyridin-4-olate | 1 |
| 198348-89-9 | 5-Nitro-1H-pyrazole-3-carboxylic acid | 1 |
| 198470-84-7 | Parecoxib | 1 |
| 198470-85-8 | Parecoxib Sodium | 1 |
| 198471-06-6 | N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]acetamide | 1 |
| 198480-21-6 | 1-(4-(2-(Azepan-1-yl)ethoxy)benzyl)-5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indole | 1 |
| 198481-32-2 | Bazedoxifene | 1 |
| 198481-33-3 | Bazedoxifene acetate | 1 |
| 198637-52-4 | Gadobutrol monohydrate | 1 |
| 198818-02-9 | 3`,5`-Dihydrodiol Simvastatin | 1 |
| 198904-31-3 | Atazanavir | 1 |
| 198904-84-6 | Atazanavir Impurity 12 | 1 |
| 198904-85-7 | 2-[[4-(2-Pyridinyl)phenyl]methyl]hydrazinecarboxylic Acid 1,1-Dimethylethyl Ester | 1 |
| 198904-86-8 | Atazanavir EP Impurity J | 1 |
| 198904-87-9 | Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir Trihydrochloride | 1 |
| 198976-06-6 | Dihydro Artemisinin-Beta-D-Glucuronide | 1 |
| 198976-43-1 | (R)-Piperidin-3-ol Hydrochloride | 1 |
| 199014-26-1 | Galantamine N-Oxide | 1 |
| 199119-58-9 | Trifloxysulfuron Sodium | 1 |
| 199188-97-1 | N-Formyl Fluoxetine | 1 |
| 199191-66-7 | (S)-Duloxetine Succinamide | 1 |
| 199191-67-8 | (S)-Duloxetine Phthalamide | 1 |
| 199327-61-2 | 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one, 97% | 2 |
| 199328-10-4 | Methyl Oxindole-5-carboxylate | 1 |
| 199330-64-8 | Methyl -Amino-2,3-Dihydro-1H-Indene-2-carboxylatehydrochloride | 1 |
| 199387-73-0 | Pantoprazole Magnesium | 1 |
| 199657-47-1 | Givinostat Acid Impurity | 1 |
| 199664-70-5 | 5-(2-Fluorophenyl)-5-oxovaleric Acid | 1 |
| 199734-71-9 | 2-Desaminosulfonyl 3-Aminosulfonyl Dorzolamide | 1 |
| 199734-72-0 | Dorzolamide N-Sulfonamide Dimer | 1 |
| 199739-10-1 | Paliperidone palmitate | 1 |
| 200115-86-2 | H-Arg(Pbf)-OH | 1 |
| 200344-33-8 | FMOC-D-Citrulline | 1 |
| 200396-19-6 | (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate | 1 |
| 200396-21-0 | (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate | 1 |
| 200509-41-7 | Quizalofop-p-tefury solution | 1 |
| 200556-62-3 | Pentoxifylline EP Impurity H | 1 |
| 200563-87-7 | 3-(p-Toluenesulfonate)-N-methyl-N-boc-propylamine | 1 |
| 200575-15-1 | 4-[[2-Ethoxy-5-[(4-methyl-1-piperazinyl)- sulfonyl]benzoyl]amino]-1-methyl-3-propyl- 1H-pyrazole-5-carboxamide | 1 |
| 200623-62-7 | Fmoc-D-Gln(Trt)-OH, 97% | 1 |
| 200628-33-7 | (1R)-N-Benzylindan-1-amine Hydrochloride | 1 |
| 200630-46-2 | 3-Methoxy-L-Tyrosine Monohydrate | 1 |
| 200630-96-2 | N-(3-AcetylPhenyl) N-Ethylacetamide | 1 |
| 200636-63-1 | Thyropropic Acid (Stage-2) | 1 |
| 200707-85-3 | Cetirizine Amide Dihydrochloride | 1 |
| 200801-70-3 | rac-5-Hydroxymethyl Tolterodine | 1 |
| 200815-49-2 | Arformoterol Tartrate | 1 |
| 200880-40-6 | 1,2-Dimyristoyl-sn-glycero-3-phospho-rac-(1-glycerol) sodium salt, ≥99% | 1 |
| 201049-78-7 | Prasugrel Desacetyloxy Impurity | 1 |
| 201058-08-4 | Wang resin 1%, crosslinked 0.8 - 1 mmol/g, 200-400 mesh | 1 |
| 201166-22-5 | Propofol EP Impurity L | 1 |
| 201214-53-1 | Methyl 4-acetamido-5-iodo-2-methoxybenzoate | 1 |
| 201341-05-1 | Tenofovir Disoproxil | 1 |
| 201349-37-3 | Enisamium Iodide | 1 |
| 201360-82-9 | Desogestrel EP Impurity A | 1 |
| 201423-59-8 | Pravastatin 6'-Ketone | 1 |
| 201481-37-0 | Fmoc-L-allo-Thr(tBu)-OH | 1 |
| 201530-41-8 | Deferasirox | 1 |
| 201530-78-1 | Deferasirox EP Impurity C | 1 |
| 201530-79-2 | Deferasirox EP Impurity E | 1 |
| 201532-42-5 | Fmoc-D-Thi-OH | 1 |
| 201610-16-4 | 1,1',1'',1'''-(1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(2,2,2-trifluoroethan-1-one) | 1 |
| 201611-85-0 | 2-Cyano-2-propyl benzodithioate, 97% | 1 |
| 201611-92-9 | 4-Cyano-4-(phenylcarbonothioylthio)pentanoic acid, 98% | 1 |
| 201612-55-7 | 2-Deoxy-D-glucose-1-13C | 1 |
| 201615-38-5 | Amberlite IRA-96 Free Base | 1 |
| 201668-31-7 | Flufenacet OA | 1 |
| 201668-33-9 | Flufenacet-thioglycolate sulfoxide | 1 |
| 201733-56-4 | Bis(neopentyl glycolato)diboron, 96% | 1 |
| 201812-64-8 | Fluticasone Propionate EP Impurity H | 1 |
| 201854-22-0 | Eldecalcitol (pre-form) | 1 |
| 201855-60-9 | Paroxetine Hydrochloride Anhydrous EP Impurity H | 1 |
| 201855-71-2 | 3-Piperidinemethanol,4-(4-fluorophenyl)-1-(phenylmethyl)-,3-methanesulfonate,(3S,4R) | 1 |
| 201991-24-4 | Tert-Butyl 2-acetylpiperidine-1-carboxylate | 1 |
| 202001-00-1 | 3-Chloro-5-fluorophenylacetic acid | 1 |
| 202003-06-3 | Rufinamide Cyano Impurity | 1 |
| 202057-74-7 | (2Z)-2-Cyano-N-(4-cyanophenyl)-3-hydroxy-2-Butenamide | 1 |
| 202138-50-9 | Tenofovir Disoproxil Fumarate | 1 |
| 202189-77-3 | 2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | 1 |
| 202189-78-4 | Bilastine | 1 |
| 202189-81-9 | 2-Desetoxyethyl-4,5-Dihydrooxazole Bilastine | 1 |
| 202189-82-0 | 2-(2-(1-(4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl)piperidin-4-yl)-1H-benzo[d]imidazol-1-yl)ethan-1-ol | 1 |
| 202189-83-1 | Bilastine Hydroxy Impurity | 1 |
| 202197-26-0 | 3-Chloro-4-(3-fluorobenzyloxy)aniline | 1 |
| 202271-89-4 | (S)-Pomalidomide | 1 |
| 202271-90-7 | (R)-Pomalidomide | 1 |
| 202271-91-8 | S-Lenalidomide | 1 |
| 202289-38-1 | [Bis(2-methoxyethyl)amino]sulfur trifluoride, extra pure 50% | 2 |
| 202390-85-0 | Methyl(2S,4S,5R)-3-benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylate | 1 |
| 202407-26-9 | L-Tyrosine-13C9,15N | 1 |
| 202409-31-2 | Desmethyl Etoricoxib | 1 |
| 202409-33-4 | Etoricoxib, ≥98% | 1 |
| 202464-88-8 | (S)-Rasagiline Mesylate | 1 |
| 202467-69-4 | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid | 1 |
| 202479-37-6 | rac-Fluvastatin Methyl Ester (Mixture of Diastereomers) | 1 |
| 202480-74-8 | 1,2-Propylene-d6 Carbonate | 1 |
| 202534-94-9 | Ethyl 4-(4-fluorophenyl)-1-methyl-2,6-dioxopiperidine-3-carboxylate | 1 |
| 202656-23-3 | 1,3-Dichloropropene D4(cis/trans mixture) | 1 |
| 202658-88-6 | 2-Chloro-N-(methylsulfonyl)acetamide | 1 |
| 202816-62-4 | Ritonavir EP Impurity N | 1 |
| 202825-43-2 | 4- Fluoro Safinamide | 1 |
| 202825-45-4 | Ralfinamide Mesylate | 1 |
| 202825-46-5 | Safinamide Methanesulfonate | 1 |
| 202865-66-5 | (2-Bromo-5-fluorophenyl)methanol | 1 |
| 202865-83-6 | 3-Bromo-5-fluorotoluene, 98% | 1 |
| 202914-84-9 | Lomitapide Mesylate | 1 |
| 202917-04-2 | 3-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline | 1 |
| 203007-73-2 | Cefprozil EP Impurity L | 1 |
| 203120-46-1 | Laninamivir octanoate | 1 |
| 203264-09-9 | Miconazole Impurity H nitarte salt | 1 |
| 203265-23-0 | Cecropin B (free acid) trifluoroacetate salt | 1 |
| 203312-38-3 | Spirotetramat Metabolite cis-enol | 1 |
| 203395-59-9 | Brexpiprazole Target-24 | 1 |
| 203395-75-9 | Aripiprazole 3,4-Dichloro Impurity | 1 |
| 203395-78-2 | Aripiprazole Isomer | 1 |
| 203395-81-7 | Aripiprazole EP Impurity C | 1 |
| 203395-82-8 | Aripiprazole EP Impurity D | 1 |
| 203395-84-0 | 2-Monobromo Aripiprazole | 1 |
| 203633-12-9 | alpha-Terpineol-d3 (Propyl Methyl-d3) | 1 |
| 203633-19-6 | Dopamine-d4 Hydrochloride | 1 |
| 203645-63-0 | Amitriptyline-d6 Hydrochloride | 1 |
| 203714-71-0 | Hoveyda-Grubbs Catalyst, 1st Generation, 97% | 1 |
| 203716-10-3 | Transportan | 1 |
| 203719-54-4 | (R)-Limonene 1,2-epoxide | 1 |
| 203784-52-5 | Nortriptyline-d3 Hydrochloride | 1 |
| 203787-91-1 | Salcaprozate Sodium | 2 |
| 203806-08-0 | Ethylenediaminetetraacetic d12 Acid | 1 |
| 203866-14-2 | N-Boc-Trans-4-Fluoro-L-Proline | 1 |
| 204008-22-0 | 1-Ethyl-4-octylbenzene | 1 |
| 204204-73-9 | (Z)-2-(1-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4-mercaptopiperidin-3-ylidene)acetic Acid | 1 |
| 204205-33-4 | 2 - Bromo-2-(2-fluorophenyl)-1-cyclopropyl ethanone | 1 |
| 204254-90-0 | Oseltamivir Hydroxy Mesylate (N-2) | 1 |
| 204254-92-2 | Oseltamivir Hydroxy Mesylate | 1 |
| 204254-94-4 | (3R,4R,5R)-4-(1-Ethylpropoxy)-3-hydroxy-5-[(methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethy | 1 |
| 204254-96-6 | Ethyl | 1 |
| 204254-98-8 | (3R,4S,5R)-Ethyl 5-azido-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate | 1 |
| 204255-02-7 | (1R,5R,6R)-5-(1-Ethylpropoxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester | 1 |
| 204255-04-9 | N-Desacetyl 5-Azido Oseltamivir | 1 |
| 204255-06-1 | 5-Azido Oseltamivir | 1 |
| 204255-11-8 | Oseltamivir Phosphate | 1 |
| 204268-61-1 | N-Nitroso Maprotiline | 1 |
| 204318-14-9 | DOTA-TOC, 95% | 2 |
| 204384-71-4 | Fmoc-L-m-Tyrosine(tBu)-OH | 1 |
| 204395-49-3 | Buspirone-d8 | 1 |
| 204395-52-8 | Clozapine-d4 | 1 |
| 204589-58-2 | Ezetimibe 3-Dehydroxy Impurity | 1 |
| 204589-68-4 | Ezetimibe Anhydro (E)-Isomer | 1 |
| 204589-82-2 | (3R,4S)-1-(4-Fluorophenyl)-2-oxo-4-[4-(benzyloxy)phenyl]-3-azetidinepropanoic acid | 1 |
| 204656-20-2 | Liraglutide | 1 |
| 204688-60-8 | 2-[(3R)-1-[(tert-Butoxy)carbonyl]pyrrolidin-3-yl]acetic acid | 1 |
| 204777-78-6 | Fmoc-Lys(ivDde)-OH, ≥96% (HPLC) | 1 |
| 204913-01-9 | tert-Butyl ((1S,3R)-3-acetylcyclopentyl)carbamate | 1 |
| 205059-39-8 | 1-(1-Boc-piperidin-4-yl)piperazine Hydrochloride | 1 |
| 205105-83-5 | Beclomethasone Dipropionate EP Impurity V | 1 |
| 205252-36-4 | D-Alanyl-L-glutamine | 1 |
| 205379-07-3 | (5S)-N-Benzyloxycarbonyl-N-(5-Amino-1-carboxypentyl)iminodiacetic Acid, Tri-t-butyl Ester | 1 |
| 205393-21-1 | (αS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]-benzenepropanamide Monohydrochloride | 1 |
| 205393-22-2 | Bortezomib Pinanediol Ester Impurity | 1 |
| 205437-60-1 | rac Amphetamine-d6 Hydrochloride | 1 |
| 205448-31-3 | 4-Chloro-6-methoxyquinolin-7-ol | 1 |
| 205448-64-2 | Methyl 4-(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)-2-methoxybenzoate | 1 |
| 205448-65-3 | Methyl 7-methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate | 1 |
| 205448-66-4 | Methyl 4-chloro-7-methoxyquinoline-6-carboxylate | 1 |
| 205521-07-9 | Captopril EP Impurity H | 1 |
| 205650-65-3 | Fipronil Desulfinyl | 1 |
| 205650-69-7 | Fipronil amide | 1 |
| 205679-68-1 | 2,2,6,6-Tetramethylpiperidine-d8 -1-oxyl | 1 |
| 205754-33-2 | 8-Hydroxy Efavirenz | 1 |
| 205755-86-8 | Efavirenz Pentyne Analog | 1 |
| 205826-86-4 | Amoxicillin EP Impurity H | 1 |
| 206048-82-0 | 3-Hydroxy Darifenacin | 1 |
| 206050-23-9 | 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol | 1 |
| 206055-75-6 | DMTr-LNA-5MeU-3-CED-phosphoramidite | 1 |
| 206055-79-0 | DMT-locA(bz) Phosphoramidite | 1 |
| 206055-82-5 | DMT-locMeC(bz) Phosphoramidite | 1 |
| 206184-49-8 | Tenofovir Hydrate | 1 |
| 206361-99-1 | Darunavir | 1 |
| 206559-43-5 | 5-Bromo-1,3-dimethyl-2-iodobenzene, 97% | 1 |
| 206560-99-8 | (2S)-5,4'-Dihydroxy-7-methoxy-6-methylflavanone | 1 |
| 206658-92-6 | Tacrine Hydrochloride Monohydrate | 1 |
| 206752-32-1 | Azomethine-H monosodium salt, 95% | 1 |
| 206752-36-5 | Benzamidine hydrochloride, hydrate, ≥99% | 1 |
| 206756-25-4 | 2-(Chloromethoxy)-1,1,3,3,3-pentafluoroprop-1-ene | 1 |
| 206873-63-4 | Tariquidar | 1 |
| 206882-15-7 | 2-Amino-N-(2-(diisopropylamino)ethyl)thiazole-4-carboxamide | 1 |
| 206976-29-6 | Nicardipine Dimethyl Ester | 1 |
| 206986-88-1 | Cinchonine monohydrochloride hydrate, LR | 1 |
| 206986-90-5 | Silver(I) citrate, hydrate, ≥97% | 1 |
| 206996-60-3 | Cerium(III) acetate | 2 |
| 207121-48-0 | L-Cysteinesulfinic Acid Monohydrate | 1 |
| 207121-55-9 | 2'-Deoxyguanosine Hydrate | 1 |
| 207122-16-5 | 2,2',3,4,4',5',6-Heptabromodiphenyl ether | 1 |
| 207226-02-6 | Erlotinib Impurity B (Hydrochloride) | 1 |
| 207226-37-7 | 2,6-Difluorostyrene, 95% | 1 |
| 207230-20-4 | Caloxetate trisodium | 1 |
| 207233-95-2 | Sodium dimethyldithiocarbamate hydrate | 1 |
| 207234-02-4 | 1-Dodecylpyridinium chloride, 98% | 1 |
| 207234-04-6 | Erbium (III) Acetete | 1 |
| 207296-89-7 | 4-Benzyloxycarbonylaminopiperidine Hydrochloride | 1 |
| 207300-70-7 | D-Glucuronic acid sodium salt, 98% | 2 |
| 207300-90-1 | 1-Heptane sulphonic acid sodium salt, monohydrate, >99% | 3 |
| 207300-91-2 | 1-Hexane sulphonic acid sodium salt (monohydrate), AR, for HPLC ≥99% | 3 |
| 207398-97-8 | Indium nitrate, 99.9% | 4 |
| 207399-16-4 | Isatin-5-sulfonic acid sodium salt dihydrate | 1 |
| 207500-05-8 | Lutetium (III) Acetate | 1 |
| 207557-35-5 | (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 1 |
| 207591-86-4 | 4-Nitro-L-phenylalanine, monohydrate, 98%+ | 1 |
| 207592-21-0 | Ranitidine EP Impurity I | 1 |
| 207596-29-0 | 1-Octane sulphonic acid sodium salt (monohydrate), AR, for HPLC ≥99% | 3 |
| 207596-32-5 | Palladium(II) nitrate hydrate, 99.8% (metals basis), Pd 39% min | 1 |
| 207605-40-1 | 1-Pentane sulphonic acid sodium salt monohydrate, for HPLC ≥99.00% | 3 |
| 207670-54-0 | 11-Keto Loteprednol Etabonate | 1 |
| 207670-55-1 | Chlormethyl 17a-ethoxycarbonyloxy-3-oxoandrosta-1,4,9(11)-triene-17beta-carboxylate | 1 |
| 207670-57-3 | (8S,9R,10S,11S,13S,14S,17R)-Chloromethyl9,11-dichloro-17-((ethoxycarbonyl)oxy)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylate | 1 |
| 207670-58-4 | Chloromethyl 9-chloro-17a-ethoxycarbonyloxy-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate | 1 |
| 207671-44-1 | Quinine sulphate, GR 99%+ | 1 |
| 207671-46-3 | D-Ribose 5-phosphate disodium salt dihydrate | 1 |
| 207671-50-9 | Rutin Hydrate | 1 |
| 207679-81-0 | 5-Hydroxymethyl Tolterodine | 1 |
| 207737-97-1 | Sodium taurodeoxycholate, ≥99% | 2 |
| 207738-11-2 | Thulium(III) acetate, hydrate, 99.9% | 1 |
| 207739-72-8 | Spiro-MeOTAD, 99% | 1 |
| 207742-73-2 | o-Toluic-d7 Acid | 1 |
| 207742-88-9 | 3,4,5-Trihydroxybenzaldehyde, 98% | 1 |
| 207790-01-0 | 2-((2-(2-Methoxyethoxy)ethoxy)carbonyl) benzoic acid | 1 |
| 207801-29-4 | Yttrium(III) 2,4-pentanedionate, 99.9% | 1 |
| 207802-45-7 | Dichlorotris(1,10-phenanthroline)ruthenium(II), hydrate, 98% | 1 |
| 207804-63-5 | Dichloromethyl methyl carbonate | 1 |
| 207974-13-8 | 2,4-Dichlorobenzyl alcohol EP Impurity G | 1 |
| 207986-20-7 | Nilotinib Impurity 52 | 1 |
| 208107-10-2 | 3-Methyl-d3-1,1-diphenylurea | 1 |
| 208107-14-6 | Temozolomide-d3 | 1 |
| 208122-06-9 | Bicalutamide Impurity 10 | 1 |
| 208176-48-1 | Ethyl 4-(methyl(nitroso)amino)benzoate | 1 |
| 208192-12-5 | L-Menthyl Glyoxylate Hydrate | 1 |
| 208255-80-5 | N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester | 1 |
Or browse by name